News|Articles|November 17, 2026

The DOL PBM Disclosure Rule Puts Pharmacy Clawbacks on the Table—Pharmacy Teams Should Be Ready

Listen
0:00 / 0:00

Key Takeaways

  • PBMs must disclose compensation streams to large self-insured plan fiduciaries, including manufacturer rebates, administrative fees, spread pricing by drug/channel, and post-adjudication clawbacks or retroactive adjustments.
  • Required transparency extends to formulary decision rationales, price protection agreements, and steering toward PBM-owned mail-order or specialty pharmacies, enabling employer scrutiny of access and cost tradeoffs.
SHOW MORE

A new US DOL rule will require PBMs to disclose their compensation to large self-insured employer plans starting in 2027.

The US Department of Labor (DOL) finalized a rule in late October that forces pharmacy benefit managers (PBMs) to disclose how they get paid to large self-insured employer plans.1,2 Employers are the audience. Pharmacies are part of the story, because several of the required disclosures describe money that moves between the PBM and the pharmacy.

What the Rule Requires

PBMs, along with affiliated brokers and consultants that expect $1000 or more in compensation, must disclose their direct and indirect pay to plan fiduciaries.2,3 That includes manufacturer rebates, administrative fees, spread pricing, and co-pay clawbacks.2,3 Spread pricing is the gap between what the plan pays for a drug and what the pharmacy receives. Clawbacks are payments recouped from pharmacies or patients after a claim adjudicates.

The rule also reaches practices that pharmacy teams know well. PBMs must report spread pricing by medication and distribution channel, steering policies that favor PBM-owned mail-order or specialty pharmacies, price protection agreements, and the reasons lower-cost alternatives sit off a formulary.3

The timeline is long. The rule applies to plan years starting on or after July 1, 2027, which means January 1, 2028, for calendar-year plans.4 PBMs must give initial written disclosures at least 90 days before a contract is signed, extended, or renewed, then report actual compensation every 6 months, or quarterly if the plan asks.3,4 Plans get annual audit rights over transaction data and drugmaker contracts.3

Who It Covers

The rule covers self-insured plans with at least 100 participants or plans sponsored by employers with at least 100 workers.2 Federal officials estimate that self-insured plans cover up to 136 million Americans and project savings of up to $22 billion over 10 years.3 That projection has not been independently verified.2 Fully insured plans and smaller employers fall outside the rule.1

Why Pharmacies Should Care

Pharmacy teams have long reported retroactive adjustments and clawbacks without any way to show an employer what happened to the money. The Improving Transparency into Pharmacy Benefit Manager Fee Disclosure rule gives employers that view for the first time. The National Community Pharmacists Association (NCPA) applauded the rule, and its policy lead said employers have been "kept in the dark for many years" about PBM fees.5 NCPA petitioned the DOL for action in August 2025.3

Steering disclosure matters as well. When a PBM favors its own mail-order or specialty pharmacy, the plan can now see the policy and ask what it costs. That puts community and independent pharmacies in a better position to make a case to employers about network design and patient access.

What the Rule Does Not Do

The rule does not set drug prices, cap co-pays, or set pharmacy reimbursement.2 It does not ban spread pricing. It gives plan fiduciaries information, and savings reach workers only if employers act on it. Employers that already use brokers and auditors will move first. Many smaller plans will need time.

Legal and Timing Risk

The Pharmaceutical Care Management Association opposes the rule and says it duplicates the Consolidated Appropriations Act of 2026 (CAA). The association also warns that the rule could push smaller PBMs out of the market and drive consolidation, and it says it is evaluating its options, so court challenges are possible before the rule takes effect.2,3 A separate CAA provision requires PBMs to pass through 100% of manufacturer rebates and discounts to group health plans for plan years starting on or after August 3, 2028.1 Pharmacy teams should treat the disclosure rule and the pass-through requirement as parts of the same shift.

What Pharmacy Teams Can Do Now:

  • Track clawbacks and retroactive adjustments by PBM, plan, and month. Clean records turn an anecdote into something an employer can verify.
  • Know your contract terms. Review how each PBM network agreement handles adjustments, reconciliation, and dispute rights. Prepare a short brief for local employers.
  • Explain how pharmacy payment adjustments work, and offer to answer questions from plan fiduciaries or their auditors.
  • Watch for steering. Note where patients are pushed to mail-order or PBM-owned specialty pharmacy, and log the impact on adherence and access.
  • Follow the court and rulemaking calendar. Disclosure obligations start in 2027, but a legal challenge could change the timeline.

The Bottom Line

This rule does not fix pharmacy reimbursement. It does change who can see the numbers. Pharmacy teams that document how PBM payments reach them, and that can explain it to employers in plain terms, will have more influence once the data starts to flow.

REFERENCES
1. Stanton TJ, Ogletree, Deakins, Nash, Smoak & Stewart. DOL final rule aims to increase drug price transparency and disclosures by PBMs. National Law Review. November 3, 2026. Accessed November 9, 2026. https://natlawreview.com/article/dol-final-rule-aims-increase-drug-price-transparency-and-disclosures-pbms
2. Final Labor Department rule forces PBMs to disclose rebates and spread pricing to employers starting in July 2027. News release. Medical Daily. November 3, 2026. Accessed November 9, 2026. https://www.medicaldaily.com/pbm-rebate-fee-disclosure-rule-employers-480718
3. Nowosielski B. PBMs must now disclose fees to employer plans under final DOL rule. Drug Topics. October 30, 2026. Accessed November 9, 2026. https://www.drugtopics.com/view/pbms-must-now-disclose-fees-to-employer-plans-under-final-dol-rule
4. Ricci TM. Labor's PBM rule gives 131,102 employer plans a 90-day clock. The Blindspot. November 9, 2026. Accessed November 9, 2026. https://theblindspotintel.substack.com/p/labors-pbm-rule-gives-131102-employer
5. NCPA applauds Department of Labor final rule on PBM transparency requirements. Pharmacy Times. October 29, 2026. Accessed November 9, 2026. https://www.pharmacytimes.com/view/ncpa-applauds-department-of-labor-final-rule-on-pbm-transparency-requirements

Related to this article